Thursday’s Daily Piece: New Regulatory Pathway for Insulin

While cost of insulin continues to be a challenge, a light of hope is on the horizon. Back in 2009, Congress passed the Biologics Price Competition and Innovation Act which creates a new regulatory pathway of approval for biologics such as insulin. Now it took 10 years of preparation to make sure all stakeholders were prepared. The new pathway is NOW open which will allow for safe and effective biosimilar and interchangable versions of biologics such as insulin. Ultimate this creates opportunity to reduce costs. This is certainly a step in the right direction. To learn more, please click below.

https://www.healio.com/endocrinology/diabetes/news/online/%7B808d5c1e-0e1c-432f-8836-48b2e10250a3%7D/fda-transitions-insulin-to-new-regulatory-pathway-opening-door-for-more-biosimilars?M_BT=4557970002905

Insulin Gains New Pathway to Increased Competition | FDA
This image has an empty alt attribute; its file name is image-6.jpeg

Please share your thoughts and subscribe to receive my blogs.

#FDA #insulin #pathway

Follow me on Twitter and Facebook @ReecesPiecesDi and Instagram.

Leave a Reply

Your email address will not be published. Required fields are marked *